vs
CORCEPT THERAPEUTICS INC（CORT）与SHOE CARNIVAL INC（SCVL）财务数据对比。点击上方公司名可切换其他公司
SHOE CARNIVAL INC的季度营收约是CORCEPT THERAPEUTICS INC的1.5倍（$297.2M vs $202.1M），CORCEPT THERAPEUTICS INC净利率更高（12.0% vs 4.9%，领先7.1%），CORCEPT THERAPEUTICS INC同比增速更快（11.1% vs -3.2%），CORCEPT THERAPEUTICS INC自由现金流更多（$38.4M vs $19.7M），过去两年CORCEPT THERAPEUTICS INC的营收复合增速更高（17.3% vs 3.0%）
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
Shoe Carnival Inc是一家美国家庭鞋类零售商，目前在美国中西部、南部、东南部地区以及波多黎各共开设了429家门店。该公司由大卫·拉塞尔于1978年创立，截至2025年，其总部位于南卡罗来纳州福特米尔。
CORT vs SCVL — 直观对比
营收规模更大
SCVL
是对方的1.5倍
$202.1M
营收增速更快
CORT
高出14.3%
-3.2%
净利率更高
CORT
高出7.1%
4.9%
自由现金流更多
CORT
多$18.7M
$19.7M
两年增速更快
CORT
近两年复合增速
3.0%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $297.2M |
| 净利润 | $24.3M | $14.6M |
| 毛利率 | 98.7% | 37.6% |
| 营业利润率 | 2.2% | 6.3% |
| 净利率 | 12.0% | 4.9% |
| 营收同比 | 11.1% | -3.2% |
| 净利润同比 | -21.0% | -23.9% |
| 每股收益（稀释后） | $0.20 | $0.53 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CORTSCVL
| Q4 25 | $202.1M | $297.2M | ||
| Q3 25 | $207.6M | $306.4M | ||
| Q2 25 | $194.4M | $277.7M | ||
| Q1 25 | $157.2M | $262.9M | ||
| Q4 24 | $181.9M | $306.9M | ||
| Q3 24 | $182.5M | $332.7M | ||
| Q2 24 | $163.8M | $300.4M | ||
| Q1 24 | $146.8M | $280.2M |
净利润CORTSCVL
| Q4 25 | $24.3M | $14.6M | ||
| Q3 25 | $19.7M | $19.2M | ||
| Q2 25 | $35.1M | $9.3M | ||
| Q1 25 | $20.5M | $14.7M | ||
| Q4 24 | $30.7M | $19.2M | ||
| Q3 24 | $47.2M | $22.6M | ||
| Q2 24 | $35.5M | $17.3M | ||
| Q1 24 | $27.8M | $15.5M |
毛利率CORTSCVL
| Q4 25 | 98.7% | 37.6% | ||
| Q3 25 | 97.8% | 38.8% | ||
| Q2 25 | 98.2% | 34.5% | ||
| Q1 25 | 98.5% | 34.9% | ||
| Q4 24 | 98.4% | 36.0% | ||
| Q3 24 | 98.4% | 36.1% | ||
| Q2 24 | 98.5% | 35.6% | ||
| Q1 24 | 98.3% | 35.6% |
营业利润率CORTSCVL
| Q4 25 | 2.2% | 6.3% | ||
| Q3 25 | 4.9% | 8.2% | ||
| Q2 25 | 13.7% | 4.3% | ||
| Q1 25 | 2.2% | 5.3% | ||
| Q4 24 | 13.9% | 8.0% | ||
| Q3 24 | 25.5% | 9.0% | ||
| Q2 24 | 21.7% | 7.5% | ||
| Q1 24 | 20.1% | 7.1% |
净利率CORTSCVL
| Q4 25 | 12.0% | 4.9% | ||
| Q3 25 | 9.5% | 6.3% | ||
| Q2 25 | 18.1% | 3.4% | ||
| Q1 25 | 13.1% | 5.6% | ||
| Q4 24 | 16.9% | 6.3% | ||
| Q3 24 | 25.9% | 6.8% | ||
| Q2 24 | 21.7% | 5.8% | ||
| Q1 24 | 18.9% | 5.5% |
每股收益（稀释后）CORTSCVL
| Q4 25 | $0.20 | $0.53 | ||
| Q3 25 | $0.16 | $0.70 | ||
| Q2 25 | $0.29 | $0.34 | ||
| Q1 25 | $0.17 | $0.53 | ||
| Q4 24 | $0.25 | $0.70 | ||
| Q3 24 | $0.41 | $0.82 | ||
| Q2 24 | $0.32 | $0.63 | ||
| Q1 24 | $0.25 | $0.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $372.2M | $107.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $647.8M | $683.2M |
| 总资产 | $836.7M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CORTSCVL
| Q4 25 | $372.2M | $107.7M | ||
| Q3 25 | $421.7M | $91.9M | ||
| Q2 25 | $342.2M | $93.0M | ||
| Q1 25 | $322.8M | $123.1M | ||
| Q4 24 | $383.3M | $91.1M | ||
| Q3 24 | $380.3M | $84.5M | ||
| Q2 24 | $473.2M | $69.5M | ||
| Q1 24 | $410.8M | $111.2M |
股东权益CORTSCVL
| Q4 25 | $647.8M | $683.2M | ||
| Q3 25 | $631.9M | $670.7M | ||
| Q2 25 | $635.8M | $653.6M | ||
| Q1 25 | $683.3M | $649.0M | ||
| Q4 24 | $679.6M | $635.7M | ||
| Q3 24 | $638.8M | $618.5M | ||
| Q2 24 | $596.2M | $597.8M | ||
| Q1 24 | $547.9M | $583.4M |
总资产CORTSCVL
| Q4 25 | $836.7M | $1.2B | ||
| Q3 25 | $823.6M | $1.2B | ||
| Q2 25 | $801.7M | $1.1B | ||
| Q1 25 | $846.5M | $1.1B | ||
| Q4 24 | $840.6M | $1.1B | ||
| Q3 24 | $784.3M | $1.1B | ||
| Q2 24 | $714.6M | $1.1B | ||
| Q1 24 | $655.9M | $1.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | $33.6M |
| 自由现金流经营现金流 - 资本支出 | $38.4M | $19.7M |
| 自由现金流率自由现金流/营收 | 19.0% | 6.6% |
| 资本支出强度资本支出/营收 | 0.0% | 4.7% |
| 现金转化率经营现金流/净利润 | 1.58× | 2.30× |
| 过去12个月自由现金流最近4个季度 | — | $35.1M |
8季度趋势，按日历期对齐
经营现金流CORTSCVL
| Q4 25 | $38.4M | $33.6M | ||
| Q3 25 | $54.5M | $13.3M | ||
| Q2 25 | $43.9M | $-9.6M | ||
| Q1 25 | $5.1M | $44.5M | ||
| Q4 24 | $59.3M | $17.3M | ||
| Q3 24 | $73.8M | $23.7M | ||
| Q2 24 | $41.2M | $17.1M | ||
| Q1 24 | $23.8M | $53.4M |
自由现金流CORTSCVL
| Q4 25 | $38.4M | $19.7M | ||
| Q3 25 | — | $2.2M | ||
| Q2 25 | $43.9M | $-23.0M | ||
| Q1 25 | $5.0M | $36.2M | ||
| Q4 24 | $59.2M | $8.3M | ||
| Q3 24 | $72.2M | $18.2M | ||
| Q2 24 | $40.8M | $6.9M | ||
| Q1 24 | — | $40.7M |
自由现金流率CORTSCVL
| Q4 25 | 19.0% | 6.6% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | 22.6% | -8.3% | ||
| Q1 25 | 3.2% | 13.8% | ||
| Q4 24 | 32.5% | 2.7% | ||
| Q3 24 | 39.5% | 5.5% | ||
| Q2 24 | 24.9% | 2.3% | ||
| Q1 24 | — | 14.5% |
资本支出强度CORTSCVL
| Q4 25 | 0.0% | 4.7% | ||
| Q3 25 | 0.0% | 3.6% | ||
| Q2 25 | 0.0% | 4.8% | ||
| Q1 25 | 0.1% | 3.2% | ||
| Q4 24 | 0.1% | 3.0% | ||
| Q3 24 | 0.9% | 1.7% | ||
| Q2 24 | 0.3% | 3.4% | ||
| Q1 24 | 0.0% | 4.5% |
现金转化率CORTSCVL
| Q4 25 | 1.58× | 2.30× | ||
| Q3 25 | 2.77× | 0.69× | ||
| Q2 25 | 1.25× | -1.03× | ||
| Q1 25 | 0.25× | 3.04× | ||
| Q4 24 | 1.93× | 0.90× | ||
| Q3 24 | 1.56× | 1.05× | ||
| Q2 24 | 1.16× | 0.99× | ||
| Q1 24 | 0.86× | 3.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
